AFJKNasdaqBlank ChecksFiscal year ends December 31Also trades as AFJKR, AFJKU
Aimei Health Technology Co., Ltd.
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 13, 2026
$12.27−0.00 (-0.00%)
Close on Oct 19, 2026
- Market cap
- –
- P/E (TTM)
- –
- Dividend yield
- –
Earnings
Quarterly results announced on Form 8-K, Item 2.02
No earnings releases found
Aimei Health Technology has not filed an earnings release (Form 8-K, Item 2.02) that we could match to a fiscal quarter.
Press releases
Announcements Aimei Health Technology filed with the SEC
HEALTH TECHNOLOGY CO., LTD. ANNOUNCES TERMINATION OF BUSINESS COMBINATION AGREEMENT WITH UNITED HYDROGEN GROUP INC.
Agreement terminated · Regulation FD disclosure · EX-99.1 to Form 8-K
Hydrogen Group Inc., a Comprehensive Hydrogen Solution Company in China, Announces Execution of Business Combination Agreement with Aimei
Material agreement · Regulation FD disclosure · EX-99.1 to Form 8-K
Health Technology Co., Ltd. Announces the Separate Trading of its Ordinary Shares and Rights Commencing January 22, 2024
Other events · EX-99.1 to Form 8-K
of Independent Registered Public Accounting Firm PCAOB ID 206
Other events · EX-99.1 to Form 8-K
Health Technology Co., Ltd Announces Pricing of $60 Million Initial Public Offering
Material agreement · Unregistered share sale · Charter or bylaw amendment · Other events · EX-99.1 to Form 8-K
Health Technology Co., Ltd Announces Closing of $69 Million Initial Public Offering
Material agreement · Unregistered share sale · Charter or bylaw amendment · Other events · EX-99.2 to Form 8-K